Related Experiment Video

Updated: Feb 25, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

746

Emerging molecular therapies for the treatment of acute lymphoblastic leukemia

Monali Vasekar1, Joshua E Allen, Jamal Joudeh

  • 1Department of Medicine (Hematology/Oncology), Penn State Hershey Cancer Institute and Penn State Hershey Medical Center, Hershey, PA 17033, USA.

Advances in Experimental Medicine and Biology
|January 5, 2013
PubMed

Insights

Novel therapies are being investigated for adult acute lymphoblastic leukemia (ALL), offering new hope for sustained remission. This research focuses on targeted agents and immunotherapy for Philadelphia chromosome-negative ALL.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Advances in molecular biology have identified new targets for cancer therapies.
  • Pediatric acute lymphoblastic leukemia (ALL) treatment is successful, but adult ALL remission remains challenging.
  • Existing therapies have improved survival for adult ALL patients.

Purpose of the Study:

  • To review novel therapeutic options for adult Philadelphia chromosome-negative ALL.
  • To discuss emerging targeted agents and immunotherapies.
  • To explore the potential of these therapies as single or adjuvant treatments.

Main Methods:

  • Review of clinical investigations for novel ALL therapies.
  • Discussion of targeted agents, including immunotherapy, monoclonal antibodies, and small molecules.
  • Focus on therapies for Philadelphia chromosome-negative adult ALL.

Main Results:

  • Several novel molecular targets are being investigated for ALL treatment.
  • Emerging therapies show promise for improving outcomes in adult ALL.
  • Immunotherapy, monoclonal antibodies, and small molecules are key areas of research.

Conclusions:

  • Novel molecular understanding is driving the development of new ALL therapies.
  • Targeted agents and immunotherapies represent promising avenues for adult ALL management.
  • Further clinical investigation is crucial to optimize treatment strategies for adult ALL.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

849
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.7K